Rancho Santa Margarita, CA1 Active Studies

Prurigo Nodularis Clinical Trials in Rancho Santa Margarita, CA

Find 1 actively recruiting prurigo nodularis clinical trials in Rancho Santa Margarita, CA. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
18
Enrolling

Recruiting Prurigo Nodularis Studies in Rancho Santa Margarita

About Prurigo Nodularis Clinical Trials in Rancho Santa Margarita

Prurigo nodularis is a chronic skin condition characterized by intensely itchy, hard lumps on the skin that develop from repeated scratching. It significantly impacts quality of life and sleep. Treatment includes topical therapies, phototherapy, and newer targeted biologics.

There are currently 1 prurigo nodularis clinical trials recruiting participants in Rancho Santa Margarita, CA. These studies are seeking a combined 18 participants. Research is being sponsored by Sanofi. Clinical trial participation is free and participants receive study-related medical care at no cost.

Prurigo Nodularis Clinical Trials in Rancho Santa Margarita — FAQ

Are there prurigo nodularis clinical trials in Rancho Santa Margarita?

Yes, there are 1 prurigo nodularis clinical trials currently recruiting in Rancho Santa Margarita, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Rancho Santa Margarita?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rancho Santa Margarita research site will contact you about next steps.

Are clinical trials in Rancho Santa Margarita free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rancho Santa Margarita studies also compensate for your time and travel.

What prurigo nodularis treatments are being tested?

The 1 active trials in Rancho Santa Margarita are testing new therapies including novel drugs, biologics, and treatment approaches for prurigo nodularis.

Data updated March 2, 2026 from ClinicalTrials.gov